Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−153.09 MHKD
43.38 MHKD
709.86 M
Om CLOVER BIOPHARMACEUTICALS LTD
Sektor
Bransch
VD
Joshua Liang
Webbplats
Huvudkvarter
Shanghai
Employees (FY)
387
Grundat
2018
FIGI
BBG0135F03T5
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
